Long-acting second-generation antipsychotics, beyond efficacy: a 12-month prospective study on patients' attitudes towards treatment

被引：0
|
作者：
Pietrini, F. [1 ]
Spadafora, M. [1 ]
Talamba, G. A. [1 ]
Godini, L. [1 ]
Santangelo, A. [1 ]
Chiarello, F. [1 ]
Ballerini, A. [1 ]
机构：
[1] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, Sect Neurosci, Florence, Italy
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2014年 / 24卷
关键词：
SCHIZOPHRENIA;
D O I：
10.1016/S0924-977X(14)70918-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.f.013
引用
收藏
页码：S573 / S574
页数：2
相关论文
共 50 条
  • [31] ATTITUDES OF CROATIAN PATIENTS WITH SEVERE MENTAL ILLNESS TOWARDS LONG-ACTING INJECTABLE ANTIPSYCHOTICS
    Bjedov, Sarah
    Ciglar, Mirta
    Malekovic, Hrvoje
    PSYCHIATRIA DANUBINA, 2016, 28 (03) : 278 - 283
  • [32] Efficacy and Tolerability of the Long-Acting Somatostatin Analog Lanreotide in Acromegaly. A 12-Month Multicenter Study of 58 Acromegalic Patients
    Philippe Chanson
    Anne Leselbaum
    Joelle Blumberg
    Gilbert Schaison
    Pituitary, 2000, 2 (4) : 269 - 276
  • [33] Combination Therapy of Long-Acting Injectable Second-Generation Antipsychotics and Oral Antipsychotics A Retrospective Chart Review and Prescribers' Attitude Survey
    Misawa, Fuminari
    Amemiya, Ami
    Fujii, Yasuo
    Takeuchi, Hiroyoshi
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2022, 42 (01) : 81 - 86
  • [34] Long-acting injectable antipsychotics: second-generation compared to first-generation drugs. Clinical outcomes and reflections
    Parise, V. Fricchione
    Addeo, L.
    Laezza, R.
    Balletta, G.
    Manna, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S535 - S536
  • [35] Long acting antipsychotics treatment of schizophrenia: A 24-month prospective study on patient's attitude towards treatment
    Calderani, E.
    Pietrini, F.
    Burian, I.
    Chiarello, F.
    Dahlke, D.
    Gemignani, S.
    Marino, P.
    Talamba, G. A.
    Poli, L.
    Santangelo, A.
    Ricca, V.
    Ballerini, A.
    EUROPEAN PSYCHIATRY, 2017, 41 : S188 - S188
  • [36] PRODUCT ENTRY SEQUENCE AND PRIORITY OF FOLLOW-ON DRUG USE: A CASE STUDY OF SECOND-GENERATION ANTIPSYCHOTICS WITH LONG-ACTING INJECTIONS
    Wang, I. T.
    Tsai, Y. W.
    Yang, S. N.
    VALUE IN HEALTH, 2024, 27 (06) : S240 - S240
  • [37] Effectiveness and Predictors of Continuation of Paliperidone Palmitate Long-Acting Injection Treatment A 12-Month Naturalistic Cohort Study
    Whale, Richard
    Pereira, Marco
    Cuthbert, Sharon
    Fialho, Renata
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2015, 35 (05) : 591 - 595
  • [38] Long-acting injectable second-generation antipsychotics: conditions of reimbursement after repeated hospitalization and estimated the budgetary impact
    Minarcikova, Ivana
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (06) : 1753 - 1753
  • [39] Healthcare resource utilization of second-generation long-acting injectable antipsychotics in schizophrenia: risperidone versus paliperidone palmitate
    Joshi, Kruti
    Pan, Xiaoyun
    Wang, Rosa
    Yang, Erru
    Benson, Carmela
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (11) : 1873 - 1881
  • [40] The effectiveness of the long-acting injections of second generation antipsychotics: A 54-month follow-up study of risperidone long-acting inyection vs paliperidone palmitate one-month formulation
    Navarro Pablo, R.
    Romero Guillena, S. L.
    Gotor Sanchez Luengo, F.
    Plasencia Garcia de Diego, B. O.
    Santamaria Gomez, O.
    EUROPEAN PSYCHIATRY, 2018, 48 : S125 - S126
12345